Clinical Trial Update: A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing torcetrapib/atorvastatin to atorvastatin alone in patients with coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Hyperlipidemia

Drugs mentioned

• Lipitor (atorvastatin)
• Torcetrapib (torcetrapib)

Snippet

Sponsor: Pfizer | Conditions: Coronary Disease, Coronary Arteriosclerosis | Phase 3 | Status: COMPLETED